NCT06326814 - A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 11, 2021

Primary Completion Date

May 5, 2023

Study Completion Date

May 5, 2023

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG

Humanized anti-Factor Bb monoclonal antibody

Pharmaceutical form:Solution for injection-Route of administration:IV and SC routes of administration

DRUG

Placebo

Pharmaceutical form:Solution for injection-Route of administration:IV and SC routes of administration

Trial Locations (2)

Parexel International Site Number : 8400003, Baltimore

Parexel International Site Number : 8400002, Glendale